Trade AstraZeneca PLC - GBP - AZNl CFD

Trading Conditions

• Type: CFD
• Spread: 0.34
• Long position overnight funding adjustment: -0.02126%
• Short position overnight funding adjustment: -0.00065%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: GBP
• Min traded quantity: 0.1
• Margin: 5.00%
• Stock exchange: United Kingdom of Great Britain and Northern Ireland
• Commission on trade: 0%
• Guaranteed stop premium: 1%

Key Stats

• Prev. Close: 142.17
• Open: 141.39
• 1-Year Change: 19.42%
• Day's Range: 139.58 - 142.43

What is AstraZeneca - GBP (AZNl)?

AstraZeneca plc is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. Established through a merger in the late 1990s, AstraZeneca specializes in treatments for diseases in areas such as oncology, cardiovascular, renal and metabolism, and respiratory. The company invests heavily in research and development to advance innovative therapies and improve patient outcomes. AstraZeneca operates worldwide, collaborating with healthcare providers, academic institutions, and other organizations to support its mission of delivering life-changing medicines.

AstraZeneca - GBP Stock Price Today: Live Overview

The price today is shaped by trading fluctuations for AstraZeneca - GBP, currently at £140.55. Price movement today covers the area between £139.36 and £142.51, with a daily shift of -1.2529%.

FAQ: AstraZeneca - GBP (AZNl)

What is the current price of AZNl stock?

AstraZeneca - GBP's current price is £140.55.

Does AZNl pay dividends?

AstraZeneca pays dividends via cash distributions (if applicable).

Does AZNl have a formal corporate presence or regional headquarters in the UAE?

AstraZeneca has a regional office in Dubai Healthcare City, UAE.

What is AZNl best known for?

AstraZeneca is most famous for its pharmaceutical products and biopharmaceutical research.

What assets are typically shown together with AZNl?

Commonly shown alongside AZNl: Novartis - CHF, SPDR MSCI Europe Energy UCITS ETF, Chugai Pharmaceutical Co., Ltd.